ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 138 filers reported holding ACCELERON PHARMA INC in Q2 2016. The put-call ratio across all filers is 6.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $43,922,000 | +734.4% | 350,000 | +222.6% | 0.09% | +616.7% |
| Q2 2018 | $5,264,000 | -14.2% | 108,500 | -36.0% | 0.01% | -29.4% |
| Q3 2016 | $6,134,000 | -37.2% | 169,500 | -41.0% | 0.02% | -37.0% |
| Q2 2016 | $9,769,000 | -4.5% | 287,500 | -25.8% | 0.03% | -3.6% |
| Q1 2016 | $10,226,000 | -45.9% | 387,500 | 0.0% | 0.03% | -44.0% |
| Q4 2015 | $18,895,000 | -17.4% | 387,500 | -57.8% | 0.05% | -21.9% |
| Q3 2015 | $22,884,000 | -38.4% | 919,055 | -21.8% | 0.06% | -31.2% |
| Q2 2015 | $37,177,000 | -18.6% | 1,175,000 | -2.1% | 0.09% | -16.2% |
| Q1 2015 | $45,672,000 | -33.9% | 1,200,000 | -32.3% | 0.11% | -34.3% |
| Q4 2014 | $69,053,000 | +30.7% | 1,772,406 | +1.4% | 0.17% | +29.0% |
| Q3 2014 | $52,842,000 | +2.3% | 1,747,406 | +14.9% | 0.13% | -1.5% |
| Q2 2014 | $51,657,000 | +11.6% | 1,520,666 | +13.3% | 0.13% | +5.6% |
| Q1 2014 | $46,306,000 | +122.7% | 1,342,197 | +155.7% | 0.13% | +129.1% |
| Q4 2013 | $20,790,000 | – | 525,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,240,173 | $31,649,000 | 3.01% |
| NEXTHERA CAPITAL LP | 178,000 | $4,543,000 | 2.66% |
| AlpInvest Partners B.V. | 23,272 | $594,000 | 2.10% |
| HARBOURVEST PARTNERS LLC | 211,928 | $5,408,000 | 1.64% |
| HAMILTON LANE ADVISORS LLC | 92,990 | $2,373,000 | 1.56% |
| Perceptive Advisors | 619,987 | $15,822,000 | 1.12% |
| SECTORAL ASSET MANAGEMENT INC | 345,225 | $8,810,000 | 0.98% |
| Casdin Capital, LLC | 45,000 | $1,148,000 | 0.95% |
| Iguana Healthcare Management, LLC | 60,000 | $1,531,000 | 0.92% |
| OAK RIDGE INVESTMENTS LLC | 1,002,334 | $25,580,000 | 0.83% |